Deutsche Bank Discusses Eli Lilly Investor Meeting

Deutsche Bank is out with a research report on Eli Lilly LLY after the company held its investor meeting yesterday. It has a Hold rating and a $38.50 price target on shares. In a note to clients, Deutsche Bank writes, "LLY remains on course with its long term growth plans, and as expected, there wasn't much incremental news on that front. Management did provide more color on expected performance metrics over the 2011-2014 (YZ) period, and it was also in line with general expectations." Shares of LLY gained 26 cents yesterday to close at $37.53, a gain of 0.7%.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetAnalyst RatingsDeutsche BankHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!